Tetravalent agonists of erythropoietin receptor

CA3328565A1Pending Publication Date: 2025-11-20EPOK THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3328565
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-13
Filing Date
2025-05-13
Publication Date
2025-11-20
Patent Text Reader

Abstract

It forms an object of the present invention a tetravalent antibody construct capable of selectively binding with high affinity to human EPOR, acting as a hEPOR agonist. It forms a further object said antibody for use in the treatment of kidney diseases and anemias.
Need to check novelty before this filing date? Find Prior Art